China Cancer Drugmaker Surges 28% in Hong Kong Trading Debut

Bloomberg2021-06-30

Hutchmed (China) Ltd., a cancer drug developer backed by billionaire Li Ka-shing, jumped in its first day of trade in Hong Kong about two years after it delayed a previous attempt to list in the city....

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

Dreamchaser9
2021-06-30
Dreamchaser9
Not interested
- hitherenou:
  why
Kohct
2021-06-30
Kohct
Like
bmng
2021-06-30
bmng
Drugs maker future bright
Willretard8
2021-06-30
Willretard8
Overcrowded
- Ameliakoh:
  Pls like n comment
Okguy86
2021-06-30
Okguy86
Cool and like pls
Valluru
2021-06-30
Valluru
Something to say

Leave a comment

256

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1124855646?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2021-06-30 10:07","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1124855646","market":"hk","top_or_hot":-1,"title":"China Cancer Drugmaker Surges 28% in Hong Kong Trading Debut","media":"Bloomberg","content":"<div>\n<p>Hutchmed (China) Ltd., a cancer drug developer backed by billionaire Li Ka-shing, jumped in its first day of trade in Hong Kong about two years after it delayed a previous attempt to list in the city....</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-06-30/china-cancer-drugmaker-surges-28-in-hong-kong-trading-debut\">Source Link</a>\n\n</div>\n","source":"lsy1584095487587","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China Cancer Drugmaker Surges 28% in Hong Kong Trading Debut</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina Cancer Drugmaker Surges 28% in Hong Kong Trading Debut\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-30 10:07 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-06-30/china-cancer-drugmaker-surges-28-in-hong-kong-trading-debut><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Hutchmed (China) Ltd., a cancer drug developer backed by billionaire Li Ka-shing, jumped in its first day of trade in Hong Kong about two years after it delayed a previous attempt to list in the city....</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-06-30/china-cancer-drugmaker-surges-28-in-hong-kong-trading-debut\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"HCM","symbol_name":"和黄医药","start_time":0,"source_url":"https://www.bloomberg.com/news/articles/2021-06-30/china-cancer-drugmaker-surges-28-in-hong-kong-trading-debut","article_id":"1124855646","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1124855646","pubTimestamp":1625018860,"sourceInfo":{"source_id":"lsy1584095487587","name":"Bloomberg"},"weMediaInfo":null,"summary":"Hutchmed (China) Ltd., a cancer drug developer backed by billionaire Li Ka-shing, jumped in its firs","collect":0,"end_time":0,"defaultTopTitle":"bloomberg.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"HCM":"和黄医药","00013":"和黄医药"},"translate_title":"中国癌症制药商在香港上市交易飙升28%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00013":0.9,"HCM":0.9},"content_text":"Hutchmed (China) Ltd., a cancer drug developer backed by billionaire Li Ka-shing, jumped in its first day of trade in Hong Kong about two years after it delayed a previous attempt to list in the city.\nShares of the biopharmaceutical company that already trades in the U.S. and the U.K. opened at HK$51.40 on Wednesday, up 28% from their offer price of HK$40.10. Hutchmedraised$537 million in the offering. It had initially planned a listing in Hong Kong in 2019, but the plan wasshelvedamid market uncertainties at the time.\nHutchmed’s debut comes after a stellar first half of the year for first-time share sales in the Asian financial hub, with a record $28 billion raised, data compiled by Bloomberg show.\nPrior to Wednesday, almost 59% of the 44 companies that started trading in Hong Kong this year ended their first session higher than the listing price, with eight of them popping more than 50% on their debuts, data compiled by Bloomberg show.\nShares of property management firmYuexiu Services Group Ltd. ended their first day of trading on Monday flat from their IPO price of HK$4.88. That contrasts with a 259% jump forMorimatsu International Holdings, a Chinese pressure equipment manufacturer which debuted the same day. Earlier this month, China Youran Dairy Group slumped 12% after its $643 millionIPO.\nChinese bubble tea chain Nayuki Holdings Ltd. fell 5% on its Hong Kong debut on Wednesday.\nHutchmed’s stock inNew Yorkis up 3.8% this year, while the London-listed shareshave risen 3.3%.","kind":null,"is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":151073365,"gmtCreate":1625060322157,"gmtModify":1703735078837,"author":{"id":"3581782846197879","authorId":"3581782846197879","name":"Dreamchaser9","avatar":"https://static.tigerbbs.com/f4f8f000953179179078bdd5e6f748b6","vip":1,"crmLevel":3,"crmLevelSwitch":0,"idStr":"3581782846197879","authorIdStr":"3581782846197879"},"htmlText":"Not interested","listText":"Not interested","text":"Not interested","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/151073365","repostId":1124855646,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5361132,"gmtCreate":1627493458821,"gmtModify":1663231636935,"authorId":3583752006060327,"author":{"id":3583752006060327,"idStr":"3583752006060327","authorId":3583752006060327,"name":"hitherenou","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":151073365,"type":1,"supId":0,"prevId":0,"content":"<u>why</u>","text":"<u>why</u>","html":"<u>why</u>"}],"langContent":"EN"},{"id":153565120,"gmtCreate":1625036233960,"gmtModify":1703850631039,"author":{"id":"3574837020922044","authorId":"3574837020922044","name":"Kohct","avatar":"https://static.tigerbbs.com/270933c10d62e8a32b4fd6891b8697e7","vip":1,"hat":"https://static.tigerbbs.com/4c5ceab71416b120bab4604c0754b52a","crmLevel":7,"crmLevelSwitch":1,"idStr":"3574837020922044","authorIdStr":"3574837020922044"},"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/153565120","repostId":1124855646,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":153227875,"gmtCreate":1625029010497,"gmtModify":1703850506151,"author":{"id":"3578708985696768","authorId":"3578708985696768","name":"bmng","avatar":"https://community-static.tradeup.com/news/2ed5a49c9f3b4ae96450f5bc82481b64","vip":1,"hat":"https://static.tigerbbs.com/b073a07f77dbe6b3bec6b12311fde6bd","crmLevel":4,"crmLevelSwitch":0,"idStr":"3578708985696768","authorIdStr":"3578708985696768"},"htmlText":"Drugs maker future bright&nbsp;","listText":"Drugs maker future bright&nbsp;","text":"Drugs maker future bright","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/153227875","repostId":1124855646,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":153269105,"gmtCreate":1625027901207,"gmtModify":1703850478769,"author":{"id":"3581490787994555","authorId":"3581490787994555","name":"Willretard8","avatar":"https://static.tigerbbs.com/55d367736decafe822ab65564b27b8a2","vip":1,"hat":"https://static.tigerbbs.com/3b7820dfed76481d8dc4de6ac5a7a136","crmLevel":4,"crmLevelSwitch":0,"idStr":"3581490787994555","authorIdStr":"3581490787994555"},"htmlText":"Overcrowded","listText":"Overcrowded","text":"Overcrowded","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/153269105","repostId":1124855646,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5079066,"gmtCreate":1625043284589,"gmtModify":1663230329046,"authorId":3574754838536636,"author":{"id":3574754838536636,"idStr":"3574754838536636","authorId":3574754838536636,"name":"Ameliakoh","avatar":"https://static.tigerbbs.com/4a747ab791603fb0a649736b10ec7454","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":153269105,"type":1,"supId":0,"prevId":0,"content":"Pls like n comment","text":"Pls like n comment","html":"Pls like n comment"}],"langContent":"EN"},{"id":153213472,"gmtCreate":1625026860396,"gmtModify":1703850451802,"author":{"id":"3581855628291300","authorId":"3581855628291300","name":"Okguy86","avatar":"https://static.tigerbbs.com/6b2a3abec63285449f77a4256eaf29b4","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3581855628291300","authorIdStr":"3581855628291300"},"htmlText":"Cool and like pls","listText":"Cool and like pls","text":"Cool and like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/153213472","repostId":1124855646,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":153236971,"gmtCreate":1625026507393,"gmtModify":1703850441231,"author":{"id":"3575858368564778","authorId":"3575858368564778","name":"Valluru","avatar":"https://static.tigerbbs.com/02a9c96f8314ba060ee85f06d50e1df9","vip":1,"crmLevel":5,"crmLevelSwitch":0,"idStr":"3575858368564778","authorIdStr":"3575858368564778"},"htmlText":"Something to say","listText":"Something to say","text":"Something to say","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/153236971","repostId":1124855646,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":256,"commentSize":45,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1124855646"}